Australia's USD 6+ Billion Medical Device Contract Manufacturing Market: Trends and Growth Forecasts to 2035 | Therapeutic Devices Lead With 31% Market Share
Dublin, May 06, 2026 (GLOBE NEWSWIRE) -- The "Australia Medical Device Contract Manufacturing Market - Distribution by Application Area, Target Therapeutic Area, and Device Class: Industry Trends and Forecasts, till 2035" has been added to ResearchAndMarkets.com's offering.
The Australia medical device contract manufacturing market is poised for dramatic expansion, projected to grow from USD 6 billion currently to USD 18.23 billion by 2035, achieving a CAGR of 13% during this period.
The market's growth is driven by rising chronic disease prevalence requiring continuous medical oversight. Patients face accessibility challenges, leading to increased demand for medical devices and smart wearables enabling remote health monitoring. Over two million types of medical devices exist globally, facilitating patient adherence and geographically unrestricted treatment. Contract manufacturing offers firms advantages like reduced setup costs and focused core operations. Services include device development, manufacturing, quality assurance, regulatory support, and supply chain management.
Key growth drivers include an aging population, demand for advanced technology, and patient-oriented devices for disease management. These drivers necessitate sophisticated remote monitoring devices for efficient health metrics tracking.
Australia's market shows robust short-term growth, bolstered by outsourcing trends and demand for advanced devices such as next-generation implants, diagnostics, and wearable health monitors. The aging population triggers partnerships between OEMs and local CDMOs, ensuring cost and time efficiencies through specialized capabilities in complex device assembly and regulatory compliance.
Growth Drivers: Strategic Enablers of Market Expansion
Increasing need for diagnostics, implants, and home-use equipment propels demand for advanced devices, encouraging outsourcing to specialized contract manufacturers. Technological advancements like automation, 3D printing, and AI quality control enhance prototyping and scalability, attracting biotech, MedTech firms, and giants like Pfizer and Novartis leveraging local CDMOs.
Market Challenges: Critical Barriers Impeding Progress
Challenges persist due to compliance with TGA's rigorous standards, causing documentation burdens and delays in market entry. Global supply chain disruptions result in raw material shortages, while competition from low-cost manufacturers pressures pricing. Skilled labor shortages, particularly in cleanroom operations and regulatory affairs, further strain capacity.
Therapeutic Medical Devices Dominating Market Segment
Therapeutic devices lead with 31% market share due to demand for managing chronic conditions. Drug delivery devices exhibit the highest growth potential with increased focus on conditions like obesity and diabetes requiring constant monitoring.
Orthopedic Disorders: Leading Market Segment
Orthopedic disorders represent the largest share (20.9%) by 2035, driven by rising demand for joint replacements. Metabolic disorders show significant growth potential due to increasing conditions like obesity and hypertension, necessitating ongoing health monitoring.
Australia Medical Device Contract Manufacturing Market: Key Segments
Application Areas
Device Class
Target Therapeutic Area
Key Questions Answered in this Report
Reasons to Buy this Report
A selection of companies mentioned in this report includes, but is not limited to:
For more information about this report visit https://www.researchandmarkets.com/r/e7q7th
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.